Close Menu

NEW YORK (GenomeWeb) – Consumer wellness startup Onegevity Health said today that it has signed a licensing agreement with Kirin Holdings and Mitsui to launch Onegevity's testing system in Japan and to develop unique nutritional products using the firm's AI-based platform.

As part of the collaboration, the partners will start offering Onegevity's GutBio assay, which combines metagenomic sequencing with AI-based personalized recommendations to increase gut the user's health, in Japan.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.